Our results indicate that gelatinolytic activities of MMP-2 or MMP-9 are not required for collagen I invasion by ovarian cancer cells as treatment with the MMP-2/MMP-9 inhibitor SB-3CT caused only a small reduction in invasion. This evidence concerns the gene MMP2 and ovarian carcinoma.